NACFC offers an opportunity to showcase your research at the premier gathering of CF health care professionals and research scientists from around the world.
Guidelines and Presenting Information
- Submission Rules & Instructions
Some of our submission requirements have changed, please carefully review the submission instructions and rules and guidelines for categorizing abstracts that can be found in the Downloads section of this page.
- Publication of Accepted Abstracts
All accepted abstracts will be published as a supplement to the Journal of Cystic Fibrosis (JCF). JCF will publish all accepted abstracts online on two websites: the JCF website and ScienceDirect (an Elsevier portal that delivers journal content to universities and institutions.) The abstracts will be numbered in a fully searchable PDF format.
- Accepted Abstracts: Poster Presentation
All accepted poster presenters are required to register for NACFC. Accepted abstracts will be displayed in the onsite poster gallery in the Exhibit Hall.
Poster presenters are required to bring their printed poster(s) and set up on the assigned poster board no later than Thursday, November 2 by 8:00 a.m. MT before the poster hall opens. Additionally, presenting authors must be present during the formal poster session scheduled on Friday, November 3, 2023. Odd-numbered poster presenters will be required to be present from 11:40 p.m. - 12:40 p.m. MT and even-numbered poster presenters will be required to be present from 12:40 p.m. - 1:40 p.m. MT. Additional details on poster printing requirements and poster session will be included in the acceptance notification.
- Accepted Abstracts: Oral Presentation
In addition to being presented in poster form, certain abstracts will be selected for oral presentation for one of the three specific session types described below. If an author's abstract is accepted for oral presentation, they will receive a notification with detailed instructions.
- Workshop presentations: 2-hour interactive session; consists of five 15-minute presentations, each followed by 8 minutes of discussion.
- Thematic Poster Sessions: Consist of two key parts: (1) poster presentations of abstracts focused on a central theme followed by a (2) moderated discussion that ties together ideas from multiple posters in the session.
- Rapid Fire Poster Talks: 40-minute session; poster presenters will have 5 minutes to succinctly present the essence of their poster.
- Best Abstract Awards for Junior Investigators
First (presenting) authors of abstracts who are enrolled in a graduate program or, at the time of the conference, are a post-doctoral or clinical fellow, are eligible to participate in a competition for two awards: (1) "Junior Investigator Best Abstract in Basic Science Award;" and (2) "Junior Investigator Best Abstract in Clinical Research Award." The five highest-scoring abstracts will be chosen for oral presentation during the Junior Investigator Sessions, designed to highlight abstracts by junior investigators in the field of CF basic science and clinical research.
Information about award eligibility requirements will be provided on the abstract submission website. If you would like to participate in this competition and you meet the eligibility criteria, select the appropriate option when submitting your abstract(s). Please note that if selected, you must be present for the poster judging scheduled on Thursday, November 2, 2023, from 12:00 p.m. - 1:30 p.m. MT. Additionally, if selected to move forward for the final round of the competition, you must be present for the Junior Investigators session scheduled on Friday, November 3, 2023, from 5:45 p.m. - 6:45 p.m. MT. Additional details will be provided in your status notification.
For questions, please contact us at firstname.lastname@example.org.